The cycle of informative health conferences that the Hospital de Bellvitge (HUB) is carrying out to celebrate its 50th anniversary had two new sessions this week. Their topics were the “10 ways to take care of the heart” in el Prat (11 May), and “Treatment and prevention for stroke” in l’Hospitalet (12 May). Both sessions, which were very participative, received a great response from the public.

On Tuesday 10 May, the farewell ceremony and presentation of diplomas to the residents who completed their training period at the Bellvitge University Hospital and the South Metropolitan Primary Care took place. 85 residents from the hospital and 27 from Primary Care bade farewell.

Sport and research go hand in hand in a solidarity initiative that seeks to raise awareness about Amyotrophic Lateral Sclerosis (ALS) and to raise funds for research into this disease. "They against ALS" is a campaign promoted by the research group in neurological diseases and neurogenetics of IDIBELL and the Functional Unit of Motor Neuron Disease of the Neurology Service of the Bellvitge University Hospital (HUB). It also counts on the support of the Fundació Catalana d'ELA Miquel Valls and the University of Barcelona (UB).

The Gynaecology Service of Bellvitge University Hospital (HUB) has incorporated a CO2 laser to treat the symptoms of vaginal atrophy and dryness that affect many women undergoing treatment for some type of gynaecological cancer, such as breast, ovarian or cervical cancer.

The University of Barcelona (UB) held yesterday, for the first time, an event to honour the contribution of its chairs to the fields of teaching and research. One of them is the one promoted by Bellvitge University Hospital and ABEX Excelencia Robótica to progress toward the clinical care of the future.

A study led by the Primary Immunodeficiency Unit of Bellvitge University Hospital (HUB) and the Bellvitge Biomedical Research Institute (IDIBELL) shows that vaccines against SARS-CoV-2 are safe and effective for most immunodeficiency patients.